Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-22), GHW International's Beta is 2.1452.
Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.
Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
GHW International Beta Related Terms
GHW International Beta Historical Data
* Premium members only.
The historical data trend for GHW International's Beta can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, GHW International's Beta, along with its competitors' market caps and Beta data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GHW International Beta vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, GHW International's Beta distribution charts can be found below:
* The bar in red indicates where GHW International's Beta falls into.
Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.
GHW International (HKSE:09933) has a Beta of 2.1452 as of Aug. 22, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for GHW International and its competitors.
Is GHW International's Beta too high?
GHW International's current Beta is 2.1452. Overall, GHW International has a GF Score™ of 85/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does GHW International's Beta compare to DOW?
GHW International's Beta of 2.1452 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Chemicals company?
A good Beta depends on the Chemicals industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for GHW International and its competitors. GHW International's current Beta is 2.1452. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GHW International stock overvalued right now?
Based on GuruFocus' analysis, GHW International (HKSE:09933) is currently considered Fairly Valued. The stock's GF Value™ is HK$1.79, compared to a current price of HK$1.68 — trading 6.4% below its estimated fair value. The current Beta is 2.1452. GHW International's overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For GHW International (HKSE:09933), the current Beta is 2.1452 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is GHW International (HKSE:09933) Overvalued in 2026?
Based on GuruFocus' analysis, GHW International stock appears to be undervalued.
The current stock price of HK$1.68 is trading 6.4% below its estimated GF Value™ of HK$1.79.
GuruFocus considers GHW International to be Fairly Valued.
Key valuation signals for HKSE:09933:
Beta: 2.1452
GF Value™: HK$1.79 vs. price of HK$1.68 (6.4% below fair value)
No single metric tells the full story. See the HKSE:09933 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GHW International is an applied chemical intermediates provider in the integrated chemical services market, which engages in the production and sales of chemicals and sales of chemicals produced by third-party manufacturers based in mainland China, the Southeast Asia region, Europe, and the United States. The company's business segment includes Methylamine Industry Series, Iodine derivatives and supporting products, Goldenhighway new materials, Advanced materials intermediates series, Green products, Healthcare and wellness, and Happy Elephant selections. Geographically, the company generates the majority of its revenue from the Mainland of China. It also has its presence in Europe; Vietnam; Other countries in Asia (excluding mainland China and Vietnam); and Others.
85GF Score
Get the complete analysis for HKSE:09933
Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09933 has been successfully added to your 
